Kinzalmono
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Kinzalmono, covering 2025-04-23 to 2025-04-23. Get the full timeline:
Most recent: EMA Authorised: Kinzalmono (previously Telmisartan Boehringer Ingelheim Pharma KG) (telmisartan) — Bayer AG